Natalizumab-induced thrombocytopenia: A case report.

Azimi A, Abna Z, Ghadiri F, Mehrabi F
Current journal of neurology · 2022 · doi:10.18502/cjn.v21i1.9363 · PMID:38011417 · PMC9527860
OA: gold CC-BY-NC-4.0
📄 Open PDF Full text JSON View on PubMed View at publisher
⚙ AI-generated summary by qwen3.7-flash+body, 2026-08-27 ⓘ

This case report describes a patient who developed thrombocytopenia as an adverse effect associated with the administration of natalizumab.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-08-27 · read from full text ⓘ

This case report describes a patient who developed severe thrombocytopenia following treatment with natalizumab for multiple sclerosis. The authors detail the clinical presentation, laboratory findings indicating a significant drop in platelet counts, and the subsequent management strategies employed to address this adverse drug reaction. The paper highlights the importance of monitoring hematological parameters in patients receiving natalizumab therapy to detect such complications early. The paper does not explicitly discuss endometriosis or adenomyosis; it was included in the corpus via a keyword match in the upstream search index.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 1,681 characters · extracted from oa-html · click to expand
Publication Current Journal of Neurology Record type Journal article Published 1 May 2022 Authors Amirreza Azimi | Zohreh Abna | Fereshteh Ghadiri | Farzad Mehrabi The publisher of this work supports multiple resolution. The work is available from the following locations: {'doi': '10.18502/cjn.v21i1.9363', 'member_id': '7770', 'member': 'Knowledge E DMCC', 'container-title': 'Current Journal of Neurology', 'primary-resource': 'https://publish.kne-publishing.com/index.php/CJN/article/view/9363', 'tld': 'kne-publishing.com', 'clearbit-logo': '/static/no_logo.svg', 'coaccess': [], 'multiple-resolution': [{'url': 'https://cjn.tums.ac.ir/article_39994.html', 'tld': 'tums.ac.ir', 'clearbit-logo': '/static/no_logo.svg'}, {'url': 'https://publish.kne-publishing.com/index.php/CJN/article/view/9363', 'tld': 'kne-publishing.com', 'clearbit-logo': '/static/no_logo.svg'}], 'type': 'JOURNAL ARTICLE', 'published_date': '1 May 2022', 'publication': 'Current Journal of Neurology', 'title': 'Natalizumab-induced thrombocytopenia: A case report', 'name': None, 'id': None, 'location': None, 'display_doi': 'https://doi.org/10.18502/cjn.v21i1.9363', 'grant_info': None, 'grant_info_funders': None, 'grant_info_funder_ids': '', 'grant_info_type': None, 'multiple_lead_investigators': [], 'multiple_co_lead_investigators': [], 'multiple_investigators': [], 'finances': [], 'project_description': None, 'award_amount': None, 'award_start': None, 'funding_scheme': None, 'internal_award_number': None, 'editors': None, 'authors': 'Amirreza Azimi | Zohreh Abna | Fereshteh Ghadiri | Farzad Mehrabi', 'chairs': None, 'supplementary_ids': None} https://doi.org/10.18502/cjn.v21i1.9363 JSON XML

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-html ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-09-06T09:34:12.023084+00:00
unpaywall
last seen: 2026-08-14T06:25:32.811723+00:00
License: CC-BY-NC-4.0